Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of lactic dehydrogenase determination reagent spheres, reagent spheres and microfluidic chip

A technology of lactate dehydrogenase and reagents, applied in the field of medical testing, can solve problems such as difficult freeze-drying, low sensitivity, and difficulty in rapid diagnosis of patients

Active Publication Date: 2021-08-20
GENRUI BIOTECH INC
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the activity of reduced coenzyme I (NADH) is easily interfered by various factors, and it is easily oxidized, which directly affects the measurement results of lactate dehydrogenase, resulting in low detection accuracy and low sensitivity.
In addition, it needs to rely on a large-scale automatic biochemical analyzer, which is difficult to apply to patients for rapid diagnosis, that is, POCT diagnosis
Although there are existing freeze-dried reagent balls used to detect other items, the shape of the existing freeze-dried reagent balls is poor, and it is difficult to completely freeze-dry, resulting in lower stability and accuracy.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of lactic dehydrogenase determination reagent spheres, reagent spheres and microfluidic chip
  • Preparation method of lactic dehydrogenase determination reagent spheres, reagent spheres and microfluidic chip
  • Preparation method of lactic dehydrogenase determination reagent spheres, reagent spheres and microfluidic chip

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0041] Embodiments of the present invention provide a method for preparing a lactate dehydrogenase measurement reagent ball, please refer to figure 1 The method includes the steps of:

[0042] S10: The first reagent solution and the second reagent liquid are disposed.

[0043] Among them, the first reagent solution includes the following components: the first buffer 40-200 mmol / L, iodide nitrochloride tetrazolic blue 0.1-10 g / L, first intensive 10-100 g / L and stabilizer 0.1 -10g / L, and the pH of the first reagent liquid is within the first preset. The second reagent solution includes the following components: second buffer 40-200 mmol / L, lactate 10-100 g / L, oxide coenzyme I: 10-50g / L, Huang Tip enzyme 20-100 u / L and second The excipient 10-100 g / L, and the pH of the second reagent liquid is within the second preset.

[0044] When configuring the first reagent liquid, the first buffer, iodide nitrochloride tetrazol blue, first intensive, and stabilizer is given, r...

Embodiment 1

[0079] In the present embodiment, the first buffer includes a Tris buffer, a stabilizer comprising hexahamidenesium chloride, potassium chloride, and trehalose, and the first excipient comprises water soluble starch. The second buffer includes a Tris buffer, lactate is lithium lactate, and the second excipient comprises 40,000 of trehalose and dextran.

[0080] The preparation method of the first reagent ball in the lactate dehydrogenase measurement reagent ball is as follows: a quantity of Tris buffer, iodide, iodide, magnesium chloride, potassium chloride, trehalose, water soluble starch and Water is mixed to form a first reagent solution, and adjust the pH of the first reagent solution to 7.0, and the first reagent liquid is added to form a first ice hockey having a volume of about 2.5 ul in liquid nitrogen, and the first ice hockey The first reagent ball was prepared for freeze-drying.

[0081] Among them, the first reagent solution includes the following components: Tris buff...

Embodiment 2

[0086] In the present embodiment, the first buffer includes an imidazole buffer, a stabilizer comprising sodium chloride, potassium chloride, and a first excipient comprising trehalose. The second buffer includes imidazole buffer, lactate is lithium lactate, and the second excipient comprises 10,000 sucrose and glucan.

[0087] The preparation method of the first reagent ball in the lactate dehydrogenase measurement reagent ball is as follows: a quantity of imidazole buffer, iodide, sodium chloride, potassium chloride, trehalose, and water formation A reagent solution, and adjusted the pH of the first reagent solution of 7.5, and the first ice hockey of the first reagent liquid is formed in liquid nitrogen, and the first ice hockey is refrigerated. The first reagent ball is obtained.

[0088] Among them, the first reagent solution includes the following components: imidazole buffer 40-200 mmol / L, iodide nitrogenated tetrazolic blue 0.1-10 g / L, sodium chloride 0.1-10 g / L, pot...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The embodiment of the invention relates to the technical field of medical detection, and particularly relates to a preparation method of lactic dehydrogenase determination reagent spheres, the reagent spheres and a microfluidic chip. The lactic dehydrogenase determination reagent spheres comprise a first reagent sphere and a second reagent sphere, wherein a first reagent solution forming the first reagent sphere comprises 40-200mmol / L of a first buffer solution, 0.1-10g / L of iodonitrochlorotetrazolium blue, 10-100g / L of a first excipient and 0.1-10 g / L of a stabilizer; and a second reagent solution forming the second reagent sphere comprises 40-200mmol / L of a second buffer solution, 10-100g / L of lactate, 10-50g / L of oxidized coenzyme I, 20-100U / L of diaphorase and 10-100g / L of a second excipient. During detection, the generated reduced coenzyme I (NADH) is further reacted to generate colored stable formazan, so that the concentration of lactic dehydrogenase can be quantified by detecting the absorbance at the wavelength of 490nm, and the sensitivity is greatly improved; and in addition, the first excipient and the second excipient in the dosage range can ensure that the first reagent sphere and the second reagent sphere have good morphology and re-melting solubility respectively, and have high stability and precision.

Description

Technical field [0001] Embodiments of the present invention relate to the field of medical detection, and more particularly to a method of preparing a lactate dehydrogenase measurement reagent ball, a reagent ball, a microfluidic chip. Background technique [0002] The lactate dehydrogenase is widely present in the body, the most in the liver, kidney, myocardium, skeletal muscle, pancreatic and pulmonary, and the concentration of lactate dehydrogenase in these tissues is much higher than the lactate dehydrogenase in serum. concentration. Therefore, when a small amount of tissue necrosis occurs, the lactate dehydrogenase in necrotic tissue releases blood to increase the concentration of degenerate dehydrogenase in the blood. Therefore, clinically, the concentration of lactate dehydrogenase is often used to assisted auxiliary diagnosis of myocardial infarction, liver disease and certain malignant tumors. [0003] At present, the concentration of lactate dehydrogenase in the serum i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/32C12Q1/26
CPCC12Q1/32C12Q1/26G01N2333/904G01N2333/90212C12Q2326/92Y02A50/30
Inventor 牟健汪晨宇周慧欣陈明
Owner GENRUI BIOTECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products